SEI Investments
DFTX

SEI Investments’s Definium Therapeutics DFTX Stock Holding History

SEI Investments’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.34M Buy
28,582
+465
+2% +$11.5K ﹤0.01% 2149
2026
Q1 		$531K Buy
28,117
+16,281
+138% +$276K ﹤0.01% 2630
2025
Q4 		$158K Buy
11,836
+1,421
+14% +$17.6K ﹤0.01% 2955
2025
Q3 		$123K Hold
10,415
– – ﹤0.01% 2692
2025
Q2 		$67.6K Hold
10,415
– – ﹤0.01% 2729
2025
Q1 		$60.9K Hold
10,415
– – ﹤0.01% 2665
2024
Q4 		$72.5K Hold
10,415
– – ﹤0.01% 2626
2024
Q3 		$59.3K Buy
+10,415
New +$72.4K ﹤0.01% 2620

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

SEI Investments's DFTX Position: Q2 2026 in Review

SEI Investments increased its Definium Therapeutics (DFTX) stake by 1.7% in Q2 2026, buying an estimated $11.5K and bringing the position to 28,582 shares worth $1.34M. The position accounts for ﹤0.01% of the portfolio, ranked #2149.

SEI Investments first reported a position in DFTX in Q3 2024 and has held it in 8 quarters since. 361 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

  • SEI Investments held 28,582 shares of Definium Therapeutics worth $1.34M as of Q2 2026.
  • SEI Investments bought 465 Definium Therapeutics shares in Q2 2026, an estimated $11.5K.
  • Definium Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2149 holding.
  • SEI Investments first reported a position in Definium Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • 361 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.